{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:36:03Z","timestamp":1789626963610,"version":"build-2803163510"},"reference-count":93,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Cancer J"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Allogeneic hematopoietic cell transplantation (alloHCT) is a standard curative therapy for a variety of benign and malignant hematological diseases. Previously, patients who underwent alloHCT were at high risk for complications with potentially life-threatening toxicities, including a variety of opportunistic infections as well as acute and chronic manifestations of graft-versus-host disease (GVHD), where the transplanted immune system can produce inflammatory damage to the patient. With recent advances, including newer conditioning regimens, advances in viral and fungal infection prophylaxis, and novel GVHD prophylactic and treatment strategies, improvements in clinical outcomes have steadily improved. One modality with great potential that has yet to be fully realized is targeting the microbiome to further improve clinical outcomes.<\/jats:p>\n                  <jats:p>In recent years, the intestinal microbiota, which includes bacteria, fungi, viruses, and other microbes that reside within the intestinal tract, has become established as a potent modulator of alloHCT outcomes. The composition of intestinal bacteria, in particular, has been found in large multicenter prospective studies to be strongly associated with GVHD, treatment-related mortality, and overall survival. Murine studies have demonstrated a causal relationship between intestinal microbiota injury and aggravated GVHD, and more recently, clinical interventional studies of repleting the intestinal microbiota with fecal microbiota transplantation have emerged as effective therapies for GVHD. How the composition of the intestinal bacterial microbiota, which is often highly variable in alloHCT patients, can modulate GVHD and other outcomes is not fully understood. Recent studies, however, have begun to make substantial headway, including identifying particular bacterial subsets and\/or bacterial-derived metabolites that can mediate harm or benefit. Here, the authors review recent studies that have improved our mechanistic understanding of the relationship between the microbiota and alloHCT outcomes, as well as studies that are beginning to establish strategies to modulate the microbiota with the hope of optimizing clinical outcomes.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000645","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T16:02:46Z","timestamp":1679587366000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1097","volume":"29","author":[{"given":"Florent","family":"Malard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Jenq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20250928","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41409-021-01227-8","article-title":"Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years","volume":"56","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"bib2-20250928","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41409-022-01604-x","article-title":"Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey","volume":"57","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"bib3-20250928","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib4-20250928","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41375-020-0804-2","article-title":"Treatment and unmet needs in steroid-refractory acute graft-versus-host disease","volume":"34","year":"2020","journal-title":"Leukemia"},{"key":"bib5-20250928","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2009-12-258442","article-title":"The best endpoint for acute GVHD treatment trials","volume":"115","year":"2010","journal-title":"Blood"},{"key":"bib6-20250928","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"bib7-20250928","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2020007336","article-title":"Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness","volume":"136","year":"2020","journal-title":"Blood"},{"key":"bib8-20250928","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/asheducation-2008.1.134","article-title":"Recognizing and managing chronic graft-versus-host disease","volume":"2008","year":"2008","journal-title":"Hematology"},{"key":"bib9-20250928","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib10-20250928","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","year":"2020","journal-title":"Lancet Haematol"},{"key":"bib11-20250928","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","year":"2021","journal-title":"N Engl J Med"},{"key":"bib13-20250928","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bbmt.2018.06.002","article-title":"Gastrointestinal graft-versus-host disease is a risk factor for postengraftment bloodstream infection in allogeneic hematopoietic stem cell transplant recipients","volume":"24","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib14-20250928","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","year":"2017","journal-title":"Blood"},{"key":"bib15-20250928","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1158\/1078-0432.CCR-20-3134","article-title":"Evaluation of trends and prognosis over time in patients with AML relapsing after allogeneic hematopoietic cell transplant reveals improved survival for young patients in recent years","volume":"26","year":"2020","journal-title":"Clin Cancer Res"},{"key":"bib16-20250928","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","article-title":"Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"bib17-20250928","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/s41409-019-0536-y","article-title":"Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"54","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"bib18-20250928","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/cncr.30680","article-title":"Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3\u2013mutated acute myeloid leukemia","volume":"123","year":"2017","journal-title":"Cancer"},{"key":"bib19-20250928","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2307\/3573066","article-title":"Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras","volume":"45","year":"1971","journal-title":"Radiat Res"},{"key":"bib20-20250928","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/52.2.401","article-title":"Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora","volume":"52","year":"1974","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"bib21-20250928","first-page":"i3","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years","volume":"63","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"bib22-20250928","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198302103080602","article-title":"Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings","volume":"308","year":"1983","journal-title":"N Engl J Med"},{"key":"bib23-20250928","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI43918","article-title":"Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans","volume":"120","year":"2010","journal-title":"J Clin Invest"},{"key":"bib24-20250928","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"bib25-20250928","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.20112408","article-title":"Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation","volume":"209","year":"2012","journal-title":"J Exp Med"},{"key":"bib26-20250928","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib27-20250928","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","article-title":"Intestinal Blautia is associated with reduced death from graft-versus-host disease","volume":"21","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib28-20250928","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1900623","article-title":"Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"bib29-20250928","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.2021015352","article-title":"Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease","volume":"140","year":"2022","journal-title":"Blood"},{"key":"bib30-20250928","doi-asserted-by":"crossref","first-page":"adv00374","DOI":"10.2340\/00015555-3613","article-title":"Alteration in the skin microbiome in cutaneous graft versus host disease","volume":"101","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"bib31-20250928","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41375-022-01712-z","article-title":"Disturbances in microbial skin recolonization and cutaneous immune response following allogeneic stem cell transfer","volume":"36","year":"2022","journal-title":"Leukemia"},{"key":"bib32-20250928","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","year":"2012","journal-title":"Genome Res"},{"key":"bib33-20250928","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood.2020009246","article-title":"The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury","volume":"137","year":"2021","journal-title":"Blood"},{"key":"bib34-20250928","doi-asserted-by":"crossref","first-page":"eabm8646","DOI":"10.1126\/scitranslmed.abm8646","article-title":"Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidates","volume":"14","year":"2022","journal-title":"Sci Transl Med"},{"key":"bib35-20250928","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajo.2022.04.026","article-title":"Metagenomic profiling of the ocular surface microbiome in patients after allogeneic hematopoietic stem cell transplantation","volume":"242","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"bib36-20250928","doi-asserted-by":"crossref","first-page":"692225","DOI":"10.3389\/fimmu.2021.692225","article-title":"Dental biofilm microbiota dysbiosis is associated with the risk of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"12","year":"2021","journal-title":"Front Immunol"},{"key":"bib37-20250928","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/bmt.2016.66","article-title":"Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation","volume":"51","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"bib38-20250928","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cid\/ciy711","article-title":"Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: lack of commensal sparing antibiotics","volume":"68","year":"2019","journal-title":"Clin Infect Dis"},{"key":"bib39-20250928","first-page":"339ra71","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","year":"2016","journal-title":"Sci Transl Med"},{"key":"bib40-20250928","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1016\/j.cell.2022.09.007","article-title":"Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease","volume":"185","year":"2022","journal-title":"Cell"},{"key":"bib41-20250928","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1078-0432.CCR-22-1254","article-title":"Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation","volume":"29","year":"2023","journal-title":"Clin Cancer Res"},{"key":"bib42-20250928","doi-asserted-by":"crossref","first-page":"eabo3445","DOI":"10.1126\/scitranslmed.abo3445","article-title":"Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment","volume":"14","year":"2022","journal-title":"Sci Transl Med"},{"key":"bib43-20250928","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood.2021015178","article-title":"Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease","volume":"140","year":"2022","journal-title":"Blood"},{"key":"bib44-20250928","first-page":"932.e931","article-title":"A fructo-oligosaccharide prebiotic is well tolerated in adults undergoing allogeneic hematopoietic stem cell transplantation: a phase I dose-escalation trial","volume":"27","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"bib45-20250928","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.aax3760","article-title":"Lactose drives Enterococcus expansion to promote graft-versus-host disease","volume":"366","year":"2019","journal-title":"Science"},{"key":"bib46-20250928","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1182\/blood-2003-11-3769","article-title":"Probiotic effects on experimental graft-versus-host disease: let them eat yogurt","volume":"103","year":"2004","journal-title":"Blood"},{"key":"bib47-20250928","doi-asserted-by":"crossref","first-page":"e12947","DOI":"10.1111\/ctr.12947","article-title":"Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic stem cell transplantation","volume":"31","year":"2017","journal-title":"Clin Transplant"},{"key":"bib48-20250928","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ni.3400","article-title":"Gut microbiome\u2013derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease","volume":"17","year":"2016","journal-title":"Nat Immunol"},{"key":"bib49-20250928","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2011-12-401166","article-title":"Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of \u03b1-defensins","volume":"120","year":"2012","journal-title":"Blood"},{"key":"bib50-20250928","doi-asserted-by":"crossref","first-page":"e154344","DOI":"10.1172\/jci.insight.154344","article-title":"Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation","volume":"7","year":"2022","journal-title":"JCI Insight"},{"key":"bib51-20250928","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2018-03-838193","article-title":"Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease","volume":"132","year":"2018","journal-title":"Blood"},{"key":"bib52-20250928","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.2019003990","article-title":"The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice","volume":"136","year":"2020","journal-title":"Blood"},{"key":"bib53-20250928","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1038\/s41467-019-13498-3","article-title":"Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites","volume":"10","year":"2019","journal-title":"Nat Commun"},{"key":"bib54-20250928","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cncr.34091","article-title":"The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation","volume":"128","year":"2022","journal-title":"Cancer"},{"key":"bib55-20250928","first-page":"2978","article-title":"Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT","volume":"131","year":"2018","journal-title":"Blood"},{"key":"bib56-20250928","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans","volume":"588","year":"2020","journal-title":"Nature"},{"key":"bib57-20250928","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood.2021014255","article-title":"Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant","volume":"139","year":"2022","journal-title":"Blood"},{"key":"bib58-20250928","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chom.2018.03.002","article-title":"Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice","volume":"23","year":"2018","journal-title":"Cell Host Microbe"},{"key":"bib59-20250928","doi-asserted-by":"crossref","first-page":"eaap9489","DOI":"10.1126\/scitranslmed.aap9489","article-title":"Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant","volume":"10","year":"2018","journal-title":"Sci Transl Med"},{"key":"bib60-20250928","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood.2020006923","article-title":"Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study","volume":"137","year":"2021","journal-title":"Blood"},{"key":"bib61-20250928","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2016.70.3348","article-title":"Intestinal microbiota and relapse after hematopoietic-cell transplantation","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"bib62-20250928","first-page":"i36","article-title":"The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis","volume":"63","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"bib63-20250928","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"bib64-20250928","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","year":"1995","journal-title":"J Nutr"},{"key":"bib65-20250928","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","year":"2014","journal-title":"Nature"},{"key":"bib66-20250928","doi-asserted-by":"crossref","first-page":"12699","DOI":"10.1038\/s41598-018-30783-1","article-title":"Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort","volume":"8","year":"2018","journal-title":"Sci Rep"},{"key":"bib67-20250928","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.cell.2020.04.027","article-title":"Ketogenic diets alter the gut microbiome resulting in decreased intestinal TH17 cells","volume":"181","year":"2020","journal-title":"Cell"},{"key":"bib68-20250928","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","article-title":"Microbiome-based therapeutics","volume":"20","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"bib69-20250928","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2050640620967898","article-title":"A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group","volume":"9","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"bib70-20250928","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"bib71-20250928","first-page":"S1","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"bib72-20250928","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"bib73-20250928","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S2468-1253(22)00276-X","article-title":"Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"bib74-20250928","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"bib75-20250928","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2017.02.006","article-title":"Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation","volume":"23","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib76-20250928","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.bbmt.2016.03.010","article-title":"Peritransplant serum albumin decline predicts subsequent severe acute graft-versus-host disease after mucotoxic myeloablative conditioning","volume":"22","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"bib77-20250928","first-page":"180.e181","article-title":"Enteral versus px as nutritional support after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"bib78-20250928","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/bjh.16218","article-title":"Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation","volume":"188","year":"2020","journal-title":"Br J Haematol"},{"key":"bib79-20250928","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.3390\/nu11122958","article-title":"Enteral nutrition in pediatric patients undergoing hematopoietic SCT promotes the recovery of gut microbiome homeostasis","volume":"11","year":"2019","journal-title":"Nutrients"},{"key":"bib80-20250928","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","year":"2017","journal-title":"Clin Nutr"},{"key":"bib81-20250928","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000368714","article-title":"Efficacy of enteral supplementation enriched with glutamine, fiber, and oligosaccharide on mucosal injury following hematopoietic stem cell transplantation","volume":"7","year":"2014","journal-title":"Case Rep Oncol"},{"key":"bib82-20250928","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/bloodadvances.2020002604","article-title":"Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation","volume":"4","year":"2020","journal-title":"Blood Adv"},{"key":"bib83-20250928","doi-asserted-by":"crossref","first-page":"28797","DOI":"10.1038\/srep28797","article-title":"Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions","volume":"6","year":"2016","journal-title":"Sci Rep"},{"key":"bib84-20250928","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40168-016-0178-x","article-title":"Variable responses of human microbiomes to dietary supplementation with resistant starch","volume":"4","year":"2016","journal-title":"Microbiome"},{"key":"bib85-20250928","doi-asserted-by":"crossref","first-page":"eaaz8926","DOI":"10.1126\/scitranslmed.aaz8926","article-title":"Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients","volume":"12","year":"2020","journal-title":"Sci Transl Med"},{"key":"bib86-20250928","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2021-147709","article-title":"Pooled allogenic fecal microbiotherapy MaaT013 for the treatment of steroid-refractory gastrointestinal acute graft-versus-host disease: results from the phase IIa Heracles Study and Expanded Access Program","volume":"138","year":"2021","journal-title":"Blood"},{"key":"bib87-20250928","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41409-022-01824-1","article-title":"Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease","volume":"58","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"bib88-20250928","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","article-title":"Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity","volume":"2","year":"2018","journal-title":"Blood Adv"},{"key":"bib89-20250928","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1182\/blood.V93.10.3267.410k22_3267_3275","article-title":"Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial","volume":"93","year":"1999","journal-title":"Blood"},{"key":"bib90-20250928","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V80.10.2668.2668","article-title":"Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation","volume":"80","year":"1992","journal-title":"Blood"},{"key":"bib91-20250928","doi-asserted-by":"crossref","first-page":"e105706","DOI":"10.1371\/journal.pone.0105706","article-title":"Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib92-20250928","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","year":"2013","journal-title":"Haematologica"},{"key":"bib93-20250928","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (how long study): an open-label, randomised, controlled phase 4 trial","volume":"4","year":"2017","journal-title":"Lancet Haematol"},{"key":"bib94-20250928","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2352-3026(22)00145-4","article-title":"Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial","volume":"9","year":"2022","journal-title":"Lancet Haematol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:01:02Z","timestamp":1759042862000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000645","relation":{},"ISSN":["1540-336X","1528-9117"],"issn-type":[{"value":"1540-336X","type":"electronic"},{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}